ReviewHealth science reports2026
Multidrug-Resistant Pathogen Clonal Spread in Nigeria: A Systematic Review and Meta-Analysis.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: The rapid dissemination of multidrug-resistant (MDR) bacterial clones poses a global health threat and limits treatment options. Understanding the dynamics of bacterial clones in Nigeria is essential for developing effective control strategies. This systematic review aimed to track MDR pathogen clones in Nigeria. Methods: The search of studies published from 1 January 2010 to 30 April 2025 reporting on MDR bacterial clones in Nigeria was done in Scopus, PubMed and Web of Science databases, complemented with a search in Google Scholar. The Newcastle-Ottawa Scale (NOS) adapted for cross-sectional studies was used to evaluate the risk of bias. The meta-analysis was performed using the R-Studio software version 4.4.3 and the metaprop package. Results: Twenty-three studies met the inclusion criteria and reported MDR bacterial species. The MDR bacteria had a pooled prevalence of 81.5% (95% CI: 71.4-91.6). The predominant MDR clones reported were Conclusion: This systematic review provides up-to-date data on MDR clones that might be spreading in Nigeria. Public health priority pathogens were reported to harbor international clone sequence types which includes;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.